• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

κ 阿片类物质与疼痛的调制。

Kappa opioids and the modulation of pain.

机构信息

School of Biological Sciences, Victoria University of Wellington, P.O. Box 600, Wellington, New Zealand.

出版信息

Psychopharmacology (Berl). 2010 Jun;210(2):109-19. doi: 10.1007/s00213-010-1819-6. Epub 2010 Apr 7.

DOI:10.1007/s00213-010-1819-6
PMID:20372880
Abstract

BACKGROUND AND RATIONALE

Pain is a complex sensory experience, involving cognitive factors, environment (setting, society, and culture), experience, and gender and is modulated significantly by the central nervous system (CNS). The mechanisms by which opioid analgesics work are understood, but this class of drugs is not ideal as either an analgesic or anti-hyperalgesic. Accordingly, considerable effort continues to be directed at improved understanding of nociceptor function and development of selective analgesics that do not have the unwanted effects associated with opioid analgesics.

OBJECTIVE

The purpose of this paper is to provide a review of the role of KOP receptors in the modulation of pain and highlight several chemotypes currently being explored as peripherally restricted KOP ligands.

RESULTS

A growing body of literature has shown that KOP receptors are implicated in a variety of behavioral pain models. Several different classes of peripherally restricted peptidic and nonpeptidic KOP agonists have been identified and show utility in treating painful conditions.

CONCLUSION

The pharmacological profile of KOP agonists in visceral pain models suggest that peripherally restricted KOP agonists are potentially useful for a variety of peripheral pain states. Further, clinical investigation of peripherally restricted KOP agonists will help to clarify the painful conditions where KOP agonists will be most effective.

摘要

背景和原理

疼痛是一种复杂的感觉体验,涉及认知因素、环境(环境、社会和文化)、经验以及性别,并且受到中枢神经系统(CNS)的显著调节。阿片类镇痛药的作用机制已被理解,但这类药物既不是理想的镇痛药,也不是理想的抗痛觉过敏药。因此,人们继续投入大量精力来更好地理解伤害感受器的功能,并开发选择性的镇痛药,这些镇痛药不会产生与阿片类镇痛药相关的不良影响。

目的

本文旨在综述 KOP 受体在疼痛调节中的作用,并重点介绍几种目前正在探索的作为外周限制 KOP 配体的化学型。

结果

越来越多的文献表明,KOP 受体参与了各种行为性疼痛模型。已经确定了几类不同的外周限制肽类和非肽类 KOP 激动剂,它们在治疗疼痛病症方面具有实用性。

结论

KOP 激动剂在内脏疼痛模型中的药理学特征表明,外周限制 KOP 激动剂对于各种外周疼痛状态可能是有用的。此外,对外周限制 KOP 激动剂的临床研究将有助于阐明 KOP 激动剂最有效的疼痛病症。

相似文献

1
Kappa opioids and the modulation of pain.κ 阿片类物质与疼痛的调制。
Psychopharmacology (Berl). 2010 Jun;210(2):109-19. doi: 10.1007/s00213-010-1819-6. Epub 2010 Apr 7.
2
Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.κ阿片受体激动剂介导的抗伤害感受被δ受体激动剂阻断。
Br J Pharmacol. 2015 Jan;172(2):691-703. doi: 10.1111/bph.12810. Epub 2014 Sep 5.
3
Peripheral kappa-opioid agonists for visceral pain.用于内脏痛的外周κ-阿片受体激动剂。
Br J Pharmacol. 2004 Apr;141(8):1331-4. doi: 10.1038/sj.bjp.0705763. Epub 2004 Mar 29.
4
Will peripherally restricted kappa-opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?外周受限的κ-阿片受体激动剂(pKORAs)能否减轻疼痛,同时减少阿片类药物的不良反应和滥用可能性?
J Clin Pharm Ther. 2016 Aug;41(4):371-82. doi: 10.1111/jcpt.12404. Epub 2016 Jun 1.
5
The emerging therapeutic roles of κ-opioid agonists.κ-阿片受体激动剂新出现的治疗作用。
J Opioid Manag. 2016 May-Jun;12(2):101-7. doi: 10.5055/jom.2016.0321.
6
Peripherally acting opioid analgesics and peripherally-induced analgesia.外周作用的阿片类镇痛药与外周诱导镇痛
Behav Pharmacol. 2020 Apr;31(2&3):136-158. doi: 10.1097/FBP.0000000000000558.
7
ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models.ZYKR1 是一种新型、强效、外周选择性 κ 阿片受体激动剂,可减少动物模型中的内脏痛和瘙痒。
Eur J Pharmacol. 2022 Jun 5;924:174961. doi: 10.1016/j.ejphar.2022.174961. Epub 2022 Apr 17.
8
Chemical function-based pharmacophore development for novel, selective kappa opioid receptor agonists.基于化学功能的新型选择性κ阿片受体激动剂药效团开发
J Mol Graph Model. 2008 Sep;27(2):131-9. doi: 10.1016/j.jmgm.2008.03.007. Epub 2008 Mar 28.
9
Interactions between kappa and mu opioid receptor agonists: effects of the ratio of drugs in mixtures.κ 型和 μ 型阿片受体激动剂之间的相互作用:混合物中药物比例的影响。
Psychopharmacology (Berl). 2018 Aug;235(8):2245-2256. doi: 10.1007/s00213-018-4920-x. Epub 2018 May 22.
10
Biased Opioid Ligands.偏性阿片类配体。
Molecules. 2020 Sep 16;25(18):4257. doi: 10.3390/molecules25184257.

引用本文的文献

1
Opioid receptor signaling throughout ontogeny: Shaping neural and behavioral trajectories.阿片受体信号在整个个体发育过程中的作用:塑造神经和行为轨迹。
Neurosci Biobehav Rev. 2025 Mar;170:106033. doi: 10.1016/j.neubiorev.2025.106033. Epub 2025 Jan 31.
2
Pharmacological characterization of the novel selective kappa opioid receptor agonists 10-Iodo-Akuammicine and 10-Bromo-akuammicine in mice.新型选择性κ阿片受体激动剂10-碘育亨宾碱和10-溴育亨宾碱在小鼠体内的药理学特性
Neuropharmacology. 2025 May 1;268:110316. doi: 10.1016/j.neuropharm.2025.110316. Epub 2025 Jan 23.
3
Oxycodone for analgesia in children undergoing endoscopic retrograde cholangiopancreatography: a randomized, double-blind, parallel study.

本文引用的文献

1
Delta and kappa opioid receptors as suitable drug targets for pain.德尔塔和卡帕阿片受体作为治疗疼痛的合适药物靶点。
Clin J Pain. 2010 Jan;26 Suppl 10:S10-5. doi: 10.1097/AJP.0b013e3181c49e3a.
2
Analgesic efficacy of peripheral kappa-opioid receptor agonist CR665 compared to oxycodone in a multi-modal, multi-tissue experimental human pain model: selective effect on visceral pain.在多模式、多组织的实验性人体疼痛模型中,外周κ-阿片受体激动剂CR665与羟考酮相比的镇痛效果:对内脏痛的选择性作用。
Anesthesiology. 2009 Sep;111(3):616-24. doi: 10.1097/ALN.0b013e3181af6356.
3
Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence.
羟考酮用于接受内镜逆行胰胆管造影术儿童的镇痛:一项随机、双盲、平行研究。
Front Pharmacol. 2025 Jan 8;15:1515501. doi: 10.3389/fphar.2024.1515501. eCollection 2024.
4
Impact of renal impairment on the pharmacokinetic profile of intravenous difelikefalin, a kappa opioid receptor agonist for the treatment of pruritus.肾功能损害对静脉注射地佐辛(一种用于治疗瘙痒的κ阿片受体激动剂)药代动力学特征的影响。
BMC Nephrol. 2024 Oct 14;25(1):351. doi: 10.1186/s12882-024-03790-w.
5
Synthesis and evaluation of 3,4,5-trisubstituted triazoles as G protein-biased kappa opioid receptor agonists.合成及评价 3,4,5-三取代三唑类 G 蛋白偏向性 κ 阿片受体激动剂。
Eur J Med Chem. 2024 Oct 5;276:116627. doi: 10.1016/j.ejmech.2024.116627. Epub 2024 Jun 27.
6
Quantification of observable behaviors following oral administration of oxycodone and nalfurafine in male rhesus monkeys.雄性恒河猴口服羟考酮和纳呋拉啡后可观察行为的定量分析。
Drug Alcohol Depend. 2023 Nov 1;252:110953. doi: 10.1016/j.drugalcdep.2023.110953. Epub 2023 Sep 4.
7
A Focused Review on Cognitive Improvement by the Genus L. (Sage)-From Ethnopharmacology to Clinical Evidence.唇形科鼠尾草属植物对认知功能改善作用的聚焦综述——从民族药理学到临床证据
Pharmaceuticals (Basel). 2023 Jan 23;16(2):171. doi: 10.3390/ph16020171.
8
Endometriosis and Opioid Receptors: Are Opioids a Possible/Promising Treatment for Endometriosis?子宫内膜异位症与阿片受体:阿片类药物是否可能成为治疗子宫内膜异位症的方法?
Int J Mol Sci. 2023 Jan 13;24(2):1633. doi: 10.3390/ijms24021633.
9
Evaluation of the Intracellular Signaling Activities of κ-Opioid Receptor Agonists, Nalfurafine Analogs; Focusing on the Selectivity of G-Protein- and β-Arrestin-Mediated Pathways.κ-阿片受体激动剂,纳呋拉啡类似物的细胞内信号转导活性评价;关注 G 蛋白和β-arrestin 介导途径的选择性。
Molecules. 2022 Oct 19;27(20):7065. doi: 10.3390/molecules27207065.
10
The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.κ阿片受体:多种病症的一个有前景的治疗靶点。
Front Pharmacol. 2022 Jun 20;13:837671. doi: 10.3389/fphar.2022.837671. eCollection 2022.
萨尔维诺灵A及其衍生物:免受代谢作用并不会延长其在短期全脑的停留时间。
Neuropharmacology. 2009 Sep;57(4):386-91. doi: 10.1016/j.neuropharm.2009.06.044. Epub 2009 Jul 8.
4
Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen.对强效致幻剂萨尔维诺林A的转运、体外代谢及药代动力学的评估。
Eur J Pharm Biopharm. 2009 Jun;72(2):471-7. doi: 10.1016/j.ejpb.2009.01.002.
5
Peptide kappa opioid receptor ligands: potential for drug development.肽κ阿片受体配体:药物开发潜力
AAPS J. 2009 Jun;11(2):312-22. doi: 10.1208/s12248-009-9105-4. Epub 2009 May 9.
6
Behavioural and electrophysiological characterisation of experimentally induced osteoarthritis and neuropathy in C57Bl/6 mice.C57Bl/6小鼠实验性诱导骨关节炎和神经病变的行为学及电生理学特征
Mol Pain. 2009 Apr 20;5:18. doi: 10.1186/1744-8069-5-18.
7
Peripheral mechanisms of opioid analgesia.阿片类镇痛的外周机制。
Curr Opin Pharmacol. 2009 Feb;9(1):3-8. doi: 10.1016/j.coph.2008.12.009. Epub 2009 Jan 20.
8
Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain.局部外周阿片类药物作用以及阿片类基因在神经性疼痛和炎性疼痛中的脊髓和背根神经节中的表达
Pain. 2009 Feb;141(3):283-291. doi: 10.1016/j.pain.2008.12.006. Epub 2009 Jan 14.
9
Pharmacology of metopon and other new analgesic opium derivatives.美托酮及其他新型镇痛性阿片衍生物的药理学
Ann N Y Acad Sci. 1948 Nov 1;51(Art 1):51-8. doi: 10.1111/j.1749-6632.1948.tb27250.x.
10
Effect of a kappa-opioid agonist, i.v. JNJ-38488502, on sensation of colonic distensions in healthy male volunteers.静脉注射κ-阿片受体激动剂JNJ-38488502对健康男性志愿者结肠扩张感觉的影响。
Neurogastroenterol Motil. 2009 Mar;21(3):281-90. doi: 10.1111/j.1365-2982.2008.01202.x. Epub 2008 Sep 23.